You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immune Thrombocytopenic Purpura

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ITP - Immune Thrombocytopenia Trial (hetrombopag 5mg po qd, High-dose Dexamethasone)

Not yet recruiting
  • ITP - Immune Thrombocytopenia
  • hetrombopag 5mg po qd
  • High-dose Dexamethasone
  • (no location specified)
Jul 5, 2023

Refractory Systemic Lupus Erythematosus, Lupus Nephritis, Immune Thrombocytopenia Trial in Peking (CNCT19 cell injection)

Enrolling by invitation
  • Refractory Systemic Lupus Erythematosus
  • +2 more
  • CNCT19 cell injection
  • Peking, China
    Xiaofeng Zeng
Jul 3, 2023

Immune Thrombocytopenia, Treatment Trial in Tianjin (Obinutuzumab Injection [Gazyva])

Not yet recruiting
  • Immune Thrombocytopenia
  • Treatment
  • Obinutuzumab Injection [Gazyva]
  • Tianjin, China
    Institute of Hematology and Blood Diseases Hospital, Chinese Aca
Oct 17, 2023

Primary Immune Thrombocytopenia (ITP) Trial (Ianalumab)

Not yet recruiting
  • Primary Immune Thrombocytopenia (ITP)
  • Ianalumab
  • (no location specified)
Jun 5, 2023

Primary Immune Thrombocytopenia (ITP) Trial in Singapore (Ianalumab, Placebo, Corticosteroids)

Recruiting
  • Primary Immune Thrombocytopenia (ITP)
  • Ianalumab
  • +2 more
  • Singapore, Singapore
    Novartis Investigative Site
Jan 17, 2023

ITP, Immune Thrombocytopenia Trial in Beijing (Baricitinib)

Recruiting
  • ITP
  • Immune Thrombocytopenia
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Sep 27, 2022

Primary Immune Thrombocytopenia Trial in Shandong (QL0911, Placebo comparator)

Completed
  • Primary Immune Thrombocytopenia
  • Shandong, China
    Qilu Hospital of Shandong University
Nov 20, 2022

Immune Thrombocytopenia Trial (Daratumumab Injection)

Not yet recruiting
  • Immune Thrombocytopenia
  • Daratumumab Injection
  • (no location specified)
Sep 28, 2022

Activity and Safety of Fostamatinib in Consecutive Adult ITP

Not yet recruiting
  • ITP - Immune Thrombocytopenia
  • +2 more
  • (no location specified)
Jan 12, 2023

Immune Thrombocytopenia, Treatment Trial in Tianjin (CM313 Injection)

Not yet recruiting
  • Immune Thrombocytopenia
  • Treatment
  • CM313 Injection
  • Tianjin, Tianjin, China
    Chinese Academy of Medical Science and Blood Disease Hospital
Jan 12, 2023

Immune Thrombocytopenia, Pregnancy Related Trial (intravenous immunoglobulin plus low dose recombinant human thrombopoietin

Not yet recruiting
  • Immune Thrombocytopenia
  • Pregnancy Related
  • intravenous immunoglobulin plus low dose recombinant human thrombopoietin (rhTPO)
  • intravenous immunoglobulin
  • (no location specified)
Dec 1, 2022

Immune Thrombocytopenia Trial (Terbutaline, Danazol)

Not yet recruiting
  • Immune Thrombocytopenia
  • (no location specified)
Aug 6, 2022

Relapsed/Refractory Immune Thrombocytopenia Trial in Seoul (Bortezomib)

Not yet recruiting
  • Relapsed/Refractory Immune Thrombocytopenia
  • Seoul, Korea, Republic of
  • +1 more
Oct 30, 2022

Immune Thrombocytopenia, Autoimmune Hemolytic Anemia, Evans Syndrome Trial in Graz (potential biomarkers)

Recruiting
  • Immune Thrombocytopenia
  • +3 more
  • potential biomarkers
  • Graz, Styria, Austria
    Pediatric Hematology-Oncology Outpatient Clinic
Sep 8, 2022

Purpura, Thrombocytopenic, Idiopathic Trial in Germany, United Kingdom, United States (BIVV009 6.5 grams, BIVV009 7.5 grams)

Completed
  • Purpura, Thrombocytopenic, Idiopathic
  • BIVV009 6.5 grams
  • BIVV009 7.5 grams
  • Georgetown, District of Columbia
  • +4 more
Apr 22, 2022

Immune Thrombocytopenia Trial in Bristol (Mycophenolate Mofetil, Prednisolone)

Completed
  • Immune Thrombocytopenia
  • Bristol, United Kingdom
    University Hospital Bristol NHS Foundation Trust
Oct 25, 2022

Primary Immune Thrombocytopenia Trial in Beijing (STSA-1301 subcutaneous injection, Placebo)

Recruiting
  • Primary Immune Thrombocytopenia
  • STSA-1301 subcutaneous injection
  • Placebo
  • Beijing, Chaoyang District, China
    Beijing Ditan Hospital,Capital Medical University
Nov 28, 2023

Purpura, Thrombocytopenic, Idiopathic, Autoimmune Thrombocytopenic Purpura, Purpura, Thrombocytopenic, Autoimmune Trial in

Terminated
  • Purpura, Thrombocytopenic, Idiopathic
  • +2 more
  • veltuzumab
  • Los Angeles, California
  • +7 more
Aug 12, 2021

Immune Thrombocytopenia, Immune Thrombocytopenic Purpura Trial in Worldwide (PRN1008)

Recruiting
  • Immune Thrombocytopenia
  • Immune Thrombocytopenic Purpura
  • Peoria, Illinois
  • +29 more
May 11, 2022

Primary Immune Thrombocytopenia Trial in Singapore (Ianalumab, Eltrombopag, Placebo)

Recruiting
  • Primary Immune Thrombocytopenia
  • Ianalumab
  • +2 more
  • Singapore, Singapore
    Novartis Investigative Site
Jan 23, 2023

Immune Thrombocytopenia Trial in Beijing (TAC, Danazol)

Recruiting
  • Immune Thrombocytopenia
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Jul 20, 2022

Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia,

Recruiting
  • Autoimmune Hemolytic Anemia
  • +5 more
  • cytokine essays
  • +6 more
  • Milano, Italy
    Fondazione Irccs Ca' Granda Ospedale Maggiore Policlinico
Jul 3, 2023

Immune Thrombocytopenic Purpura (ITP) Trial in Worldwide (eltrombopag)

Completed
  • Immune Thrombocytopenic Purpura (ITP)
  • Nyack, New York
  • +31 more
Nov 3, 2022

Immune Thrombocytopenia Trial in Beijing (Cyclosporine Oral Product, Prednisone)

Not yet recruiting
  • Immune Thrombocytopenia
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Jul 14, 2022

Immune Thrombocytopenia Trial in Suzhou (rhTPO, Herombopag)

Recruiting
  • Immune Thrombocytopenia
  • Suzhou, Jiangsu, China
    Jie Yin
Apr 19, 2022